Strizki JM, Gaspar JM, Howe JA, Hutchins B, et al. Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance. Antimicrob Agents Chemother 2024;68:e0095323.
PMID: 38047645